Cargando…

Additional effects of erythropoietin pretreatment, ischemic preconditioning, and N-acetylcysteine posttreatment in rat kidney reperfusion injury

BACKGROUND/AIM: Since the nature of ischemia/reperfusion (IR)-induced tissue damage is multifactorial and complex, in the current study, the effects of multiple treatment strategies via concomitant administration of erythropoietin (EPO) and N-acetylcysteine (NAC) with an ischemic preconditioning (IP...

Descripción completa

Detalles Bibliográficos
Autores principales: ELSHIEKH, Mohammed, KADKHODAEE, Mehri, SEIFI, Behjat, RANJBARAN, Mina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018199/
https://www.ncbi.nlm.nih.gov/pubmed/31342735
http://dx.doi.org/10.3906/sag-1812-228
_version_ 1783497308678127616
author ELSHIEKH, Mohammed
KADKHODAEE, Mehri
SEIFI, Behjat
RANJBARAN, Mina
author_facet ELSHIEKH, Mohammed
KADKHODAEE, Mehri
SEIFI, Behjat
RANJBARAN, Mina
author_sort ELSHIEKH, Mohammed
collection PubMed
description BACKGROUND/AIM: Since the nature of ischemia/reperfusion (IR)-induced tissue damage is multifactorial and complex, in the current study, the effects of multiple treatment strategies via concomitant administration of erythropoietin (EPO) and N-acetylcysteine (NAC) with an ischemic preconditioning (IPC) regimen on renal IR injury were examined. MATERIALS AND METHODS: Thirty male Wistar rats were subjected to bilateral occlusion of the renal pedicles for 50 min followed by reperfusion. EPO (1000 IU/kg) was administered for 3 days, as well as IPC before the IR and NAC (150 mg/kg) administration for 4 days after IR. The animals were randomly allocated into 6 groups (n = 5): sham, IR, EPO+IR, IPC+IR, NAC+IR, and EPO+IPC+NAC+IR. Kidney tissues and blood samples were obtained for oxidative stress, proinflammatory cytokines, and renal functional evaluations. RESULTS: IR caused significant inflammatory response, oxidative stress, and reduced renal function. Treatment with EPO, IPC, and NAC or a combination of two of them attenuated renal dysfunction and reduced the oxidative stress and inflammatory markers. Rats treated with the combination of EPO, IPC, and NAC showed a higher degree of protection compared to the other groups. CONCLUSION: These results showed that concomitant administration of EPO and IPC along with posttreatment NAC may have additive beneficial effects on kidney IR injury during IR-induced acute renal failure.
format Online
Article
Text
id pubmed-7018199
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Scientific and Technological Research Council of Turkey
record_format MEDLINE/PubMed
spelling pubmed-70181992020-03-23 Additional effects of erythropoietin pretreatment, ischemic preconditioning, and N-acetylcysteine posttreatment in rat kidney reperfusion injury ELSHIEKH, Mohammed KADKHODAEE, Mehri SEIFI, Behjat RANJBARAN, Mina Turk J Med Sci Article BACKGROUND/AIM: Since the nature of ischemia/reperfusion (IR)-induced tissue damage is multifactorial and complex, in the current study, the effects of multiple treatment strategies via concomitant administration of erythropoietin (EPO) and N-acetylcysteine (NAC) with an ischemic preconditioning (IPC) regimen on renal IR injury were examined. MATERIALS AND METHODS: Thirty male Wistar rats were subjected to bilateral occlusion of the renal pedicles for 50 min followed by reperfusion. EPO (1000 IU/kg) was administered for 3 days, as well as IPC before the IR and NAC (150 mg/kg) administration for 4 days after IR. The animals were randomly allocated into 6 groups (n = 5): sham, IR, EPO+IR, IPC+IR, NAC+IR, and EPO+IPC+NAC+IR. Kidney tissues and blood samples were obtained for oxidative stress, proinflammatory cytokines, and renal functional evaluations. RESULTS: IR caused significant inflammatory response, oxidative stress, and reduced renal function. Treatment with EPO, IPC, and NAC or a combination of two of them attenuated renal dysfunction and reduced the oxidative stress and inflammatory markers. Rats treated with the combination of EPO, IPC, and NAC showed a higher degree of protection compared to the other groups. CONCLUSION: These results showed that concomitant administration of EPO and IPC along with posttreatment NAC may have additive beneficial effects on kidney IR injury during IR-induced acute renal failure. The Scientific and Technological Research Council of Turkey 2019-08-08 /pmc/articles/PMC7018199/ /pubmed/31342735 http://dx.doi.org/10.3906/sag-1812-228 Text en Copyright © 2019 The Author(s) This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Article
ELSHIEKH, Mohammed
KADKHODAEE, Mehri
SEIFI, Behjat
RANJBARAN, Mina
Additional effects of erythropoietin pretreatment, ischemic preconditioning, and N-acetylcysteine posttreatment in rat kidney reperfusion injury
title Additional effects of erythropoietin pretreatment, ischemic preconditioning, and N-acetylcysteine posttreatment in rat kidney reperfusion injury
title_full Additional effects of erythropoietin pretreatment, ischemic preconditioning, and N-acetylcysteine posttreatment in rat kidney reperfusion injury
title_fullStr Additional effects of erythropoietin pretreatment, ischemic preconditioning, and N-acetylcysteine posttreatment in rat kidney reperfusion injury
title_full_unstemmed Additional effects of erythropoietin pretreatment, ischemic preconditioning, and N-acetylcysteine posttreatment in rat kidney reperfusion injury
title_short Additional effects of erythropoietin pretreatment, ischemic preconditioning, and N-acetylcysteine posttreatment in rat kidney reperfusion injury
title_sort additional effects of erythropoietin pretreatment, ischemic preconditioning, and n-acetylcysteine posttreatment in rat kidney reperfusion injury
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018199/
https://www.ncbi.nlm.nih.gov/pubmed/31342735
http://dx.doi.org/10.3906/sag-1812-228
work_keys_str_mv AT elshiekhmohammed additionaleffectsoferythropoietinpretreatmentischemicpreconditioningandnacetylcysteineposttreatmentinratkidneyreperfusioninjury
AT kadkhodaeemehri additionaleffectsoferythropoietinpretreatmentischemicpreconditioningandnacetylcysteineposttreatmentinratkidneyreperfusioninjury
AT seifibehjat additionaleffectsoferythropoietinpretreatmentischemicpreconditioningandnacetylcysteineposttreatmentinratkidneyreperfusioninjury
AT ranjbaranmina additionaleffectsoferythropoietinpretreatmentischemicpreconditioningandnacetylcysteineposttreatmentinratkidneyreperfusioninjury